Integrated Evidence Generation Planning I Gavin Outteridge

Change Before Change by AESARA

Episode notes

In our inaugural episode we are discussing integrated evidence generation planning (IEGP) in the pharmaceutical industry featuring our AESARA Europe Managing Director, Gavin Outteridge.

Time Stamps:

1:13 - 7:16 Defining IEGP and its Benefits

7:24 - 11:00 Shortcomings in the current evidence generation approach

11:13 - 14:45 Impact on patient outcomes

15:04 - 20:29 Challenges to the IEGP process

20:43 - 23:35 Use of technology to improve process & closing comments


Developing an integrated strategy for evidence generation (

pharmamarket accessbusinesshealthcarepatients